IE46093B1 - Food manufacture - Google Patents
Food manufactureInfo
- Publication number
- IE46093B1 IE46093B1 IE2348/77A IE234877A IE46093B1 IE 46093 B1 IE46093 B1 IE 46093B1 IE 2348/77 A IE2348/77 A IE 2348/77A IE 234877 A IE234877 A IE 234877A IE 46093 B1 IE46093 B1 IE 46093B1
- Authority
- IE
- Ireland
- Prior art keywords
- weight
- process according
- mix
- dry particulate
- particulate mixture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 235000013305 food Nutrition 0.000 title description 2
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims abstract description 57
- 239000000203 mixture Substances 0.000 claims abstract description 56
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 41
- 239000008101 lactose Substances 0.000 claims abstract description 41
- 239000000843 powder Substances 0.000 claims abstract description 37
- 239000002002 slurry Substances 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 21
- 229940126578 oral vaccine Drugs 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 238000004040 coloring Methods 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 239000004480 active ingredient Substances 0.000 claims description 31
- 235000013312 flour Nutrition 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 14
- 239000005862 Whey Substances 0.000 claims description 12
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 239000002158 endotoxin Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 2
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 17
- 238000005507 spraying Methods 0.000 abstract description 10
- 239000012876 carrier material Substances 0.000 abstract description 7
- 239000011573 trace mineral Substances 0.000 abstract description 6
- 235000013619 trace mineral Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 239000002245 particle Substances 0.000 description 29
- 238000009826 distribution Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 241000282887 Suidae Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 239000011256 inorganic filler Substances 0.000 description 2
- 229910003475 inorganic filler Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000003921 particle size analysis Methods 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- -1 oral vaccines Substances 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicinal Preparation (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a process for the preparation of a pre-mix in the form of a free-flowing particulate composition in which a minor but essential foodstuff ingredient such as an oral vaccine, a vitamin or a trace element is dispersed uniformly throughout a carrier material which forms the bulk of the pre-mix, in which the carrier material comprises a dry particulate mixture of an edible inert powder and a lactose source, the lactose content of the mixture having from about 20 to about 50% by weight, and the pre-mix is formed by intensely agitating the carrier material and simultaneously spraying the carrier material with an aqueous solution or slurry of the foodstuff ingredient, the solution or slurry being applied in an amount from about 1 to about 12% by weight of the carrier material. Preferably the solution or slurry applied to the carrier material additionally contains a food-grade colouring agent.
Description
The present invention relates to the preparation of pre-mixes useful in. the manufacture of foodstuffs for humans and for animals, which pre-mixes incorporate mi nor but essential ingredients such as oral vaccines, vitamins and trace elements.
Pre-mixes are used to assist the blending of such minor but essential ingredients into foodstuffs in a homogeneous manner, and the invention is concerned with the preparation of pre-mixes in the form of free10 flowing particulate compositions in which the minor but essential ingredient, or each such ingredient where more than one is to be incorporated in a common pre-mix, is dispersed uniformly throughout a carrier material which forms the bulk of the pre-mix.
I5 For the purposes of this specification, the expression active ingredient is used to mean any of the following: an oral vaccine; an antibiotic; a vitamin or provitamin; a trace element or mineral· a source of calcium, phosphorus, iron, manganese, copper or iodine; a growth promoter; a flavour; or a perfume.
Also for the purposes of this specification, the expression edible inert powder is used to mean any of the following: a flour; a feed meal; an organic .waste or filler used in animal foodstuffs; or an inorganic filler.
Conventional pre-mixes which typically comprise the active ingredient dispersed by mechanical means in a dry carrier such as flour or other milled grain, tend to be unsatisfactory because it is difficult to obtain a uniform dispension of the active ingredient throughout the bulk of carrier by simple mixing, especially where the active ingredient is best handled as a liquid. The invention provides a method of making a pre-mix involving simple steps and which can lead to greater uniformity of distribution of the active ingredient.
The invention provides a process for the preparation of a pre-mix,in which process a dry particulate mixture of an .
- 2 46093 as defined above edible inert powder/and a lactose source, the lactose content of the dry particulate mixture being from 20 to . 50% by weight, is intensely agitated and while so intensely agitated is sprayed with an aqueous solution or slurry of an as defined above active ingredient»/, the solution or slurry being applied in an amount of from 1 to 12? by weight of the dry particulate mixture.
Preferably the lactose content of the dry particulate mixture is at least 22? by weight, and ideally the lactose content is at least 25? by weight. Preferably the lactose content of the dry particulate mixture is not greater than 45? by weight, and ideally not greater than
? by weight.
Preferably the amount of the solution or slurry applied to the dry particulate mixture is at least 2? by weight.
Preferably the amount of the solution or slurry is not greater than 10?, and ideally not greater tnan 5?, by weight.
The edible inert powder should comprise, together with the lactose source, the bulk of the dry particulate mixture, although other materials can be present in a total amount not exceeding, say, 15? by weight of the dry particulate mixture provided that any such additional material does not interfere unduly with the flow properties of the dry particulate mixture or with the desired properties of the pre-mix when formed.
The edible inert powder can be any such powder which is essentially lactose-free, and which is not more than sparingly
- 3 46093 soluble in water. A wide range of materials can be employed, such au feed meals commonly used as ingredients in compound foodstuffs, for example milled grain, bean meal and soya meal provided that not too many oily or water-soluble components are present; organic wastes and fillers used in animal foodstuffs, suoh as beat pulp, potato pulp and feather meal; and inorganic fillers such as kaolin, kaolinite, silica and chalk. Care should be taken to ensure that the inert powder chosen is not one whose maximum permitted level in the final foodstuff to which the pre-mix is to be -added unduly restricts the formulation of the pre-mix. Preferably the inert powder chosen is one that can be included at a level of up to at least
0.5? by weight in the final foodstuff, and ideally at an inclusion level of at least jkbout} 1.5? by weight. Ideal inert powders are commercially-available flours such as wheat flour,' corn flour, rice flour and potato flour. Most commercially-available flours contain about 12? by weight of moisture, and these flours can be used to produce acceptable pre-mixes according to the invention. However, we prefer to use dried flours, ie flours having a moisture content of less than £bou^ 10? by weight. Ihe use of dried flour can impart a longer storage life to the pre-mix.
The lactose source can be any commercially-available lactose-containing composition having a sufficently high 25 lactose content and not containing a significant amount of any other ingredient which can interfere with the formation or properties of the pre-mix. A level of £bo«£ 50? lactose by
- 4 .
weight can be regarded as a practical minimum in most circumstances, and a higher level will generally be preferred. Fat is an example of an ingredient which can be undesirable in the lactose source, or for that matter in the pre-mix generally, and hence lactose sources of high fat content should be avoided. For this reason, skimmed milk is not recommended for use as a major lactose source, although in some instances minor amounts of skimmed milk powder may be incorporated provided that the bulk of the lactose in the pre-mix comes from some other source. Pure lactose powder can be used as a lactose source, but lactose powder is a relatively expensive commodity and is only preferred where, for taste reasons, other lactose sources would be unsuitable.
In a preferred embodiment of the invention particularly suitable for the preparation of pre-mixes useful in animal feedstuffs, the lactose source incorporated in the dry particulate mixture is whey powder. Whey powder typically contains about 75% by weight of lactose. In this embodiment, the dry particulate mixture should comprise from l!0 to
70? by weight of the edible inert powder and from 60 to 30% of weight of the whey powder. Preferably the edible inert powder comprises at least 50?, and ideally at least 55?, by weight of the dry particulate mixture. Preferably the edible inert powder comprises not more than
55? by weight of the dry particulate mixture. Preferably the whey powder comprises at least 35? by weight of the dry particulate mixture, and preferably the whey powder
- 5 Λ609 3 comprises not more than 50?, ideally not more than
45?, by weight of the dry particulate mixture.
A further preferred feature of the invention is the organic incorporation of a small quantity of .an edible / acid in the pre-mix. Preferably this acid should comprise from 1 to
? by weight of the pre-mix. Ideally the acid comprises at least ^bou^ 2? by weight of the pre-mix. Ideally the acid doss not comprise more than 5? by weight of the pre-mix.
Although usually the acid be incorporated in the dry particulate mixture to which the solution or slurry is applied, it can in some instances be practical and useful to incorporate some or all of the acid in the solution or slurry. Citric acid is preferred, but other edible acids such as tartaric acid and ascorbic acid can be used. Edible acid salts such as sodium di-hydrogen phosphate can be used where the presence of the sodium will not lead to undue salt balance problem in the human or animal consuming the foodstuff. We infer from in vitro tests that the presence of the edible acid enhances the release of the active ingredient when the foodstuff incorporating the pre-mix enters the gut.
A further preferred embodiment of the invention is the inclusion of a food-grade colouring agent in the aqueous solution or slurry applied to the dry particulate mixture. Preferably the colouring agent is water-soluble. The objective is to ensure that the distribution of the aqueous solution or slurry throughout .the dry particulate mixture can be seen clearly. Thus the colour chosen should be one that
- 6 4609 3 is clearly distinct from the base colour of the dry particulate mixture. In most embodiments of the invention, the base colour of the dry particulate mixture will be essentially white. Apart from this constraint, and the desirability of using a colouring agent that is cost-effective, the selection of the colour is entirely a matter of aesthetics.
The invention utilises the ability of lactose to absorb small quantities of water to form a glass-like solid. In a pre-mix prepared according to the invention, it is observed that the pre-mix comprises a multitude of small hard particles, each consisting of the edible inert powder bound by the lactose glass, distributed throughout the bulk of the dry particulate mixture. It is further observed that the active ingredient is almost wholly located in the lactose-bound particles. This is well demonstrated when a colouring agent is also included, because it is apparent to the eye that the colour is concentrated in the lactose-bound particles.
Arising from the critical selection of the proportions of the lactose to the edible inert powder, the pre-mix of the invention represents a composition which has a uniform!
distribution of particles containing the active ingredient throughout its bulk and yet is a free-flowing particulate composition having little tendency to lump or segregate. Moreover, with the aid of the colouring agent when incorporated, it is possible to perceive the uniform distribution of the particles containing the active ingredient. The pre-mix has the additional advantage that the individual
-7 4609 3 particules containing the active ingredients can be physically separated from the bulk of the edible inert powder, for example by hand or by screening, and assay of the active ingredient can be performed readily on the separated particles.
The pre-mixes of the invention are useful for a wide variety of active ingredients. However, a preferred use of these pre-mixes is in the incorporation of oral vaccines in foodstuffs. The invention is ideally suited to the preparation of pre-mixes containing endotoxins derived from bacterial strains implicated in gastro-intestinal disorders. Such endotoxins, when substantially free from association with any of the living bacteria, promote when administered orally a highly effective immune response to the bacteria. In particular this has been well demonstrated for Escherichia coli, and other gut-infective bacteria have proved susceptible also. An oral vaccine for pigs has been developed in which the endotoxins are derived from one or more of the E, coli strains 08, 045, 0138, 0139, 0141, 0149 and 0157. An animal feedstuff incorporating such an oral vaccine is described and claimed in our Patent No. 35321 , An analogous oral vaccine for calves contains endotoxins derived from one or more of the E, coli strains 08, 09, 015, 026, 0?8, 086, 0114, 0115, 0137 and 0139. The calf vaccine can in addition usefully contain endotoxins derived from Salmonella-dublin and/or Sg-tenalJa tvphimurlum.- An animal feedstuff incorporating such an oral vaccine is described and claimed in our Patent
No. 37042 . A similar oral vaccine for lambs, incorporating
- 8 46093 endotoxins derived from the E, coli strains 08, 09, 015, 020, 078, 0114, 0137 and 0139, is described in our British patent No. 1,462,384 and an animal feedstuff containing the oral vaccine is claimed therein.
Alternative active ingredients include antibiotics such as anticoccidial drugs; hormones; vitamins such as A and D, and provitamins such as beta-carotene; trace elements and minerals, such as sources of calcium, phosphorous, iron, manganese, copper and iodine; growth promoters; and flavours and perfumes. The need for such active ingredients to be present in foodstuffs for human and animal consumption is well known and well-documented in the technical literature, as also is the nature of such active ingredients and the extent to which they are available commercially. The nature of such active ingredients per se does not form part of the invention.
The concentration of the active ingredients in the aqueous solution or slurry is not critical, subject to the proviso that . the viscosity of the solution or slurry must be such that the solution or slurry can be sprayed as very fine droplets onto the dry particulate mixture.
Pre-mixes comprising more than one active ingredient can be prepared. All of the active ingredients involved can be included in a single aqueous solution or slurry if desired.
In some instances, the non-siraultaneous application of a separate solution or slurry for individual active ingredients car. be practical and advantageous. Where separate solutions or slurries are used, the incorporation of a distinctly different
- 9 4 6 0 9 3 colouring agent in each solution or slurry can enable particles containing the different active ingredients to be identified in the resulting pre-mix.
Physical preparation of the pre-mix of the invention can be accomplished using any conventional equipment capable of intensely agitating a particulate material and simultaneously finely spraying a liquid onto the particulate material. Horizontal ribbon mixers can be used, and vertical spray mixers such as the Schugi mixer represent alternatives. If desired, the pre-mix can be prepared in a fluidised bed equipped with a spray head for the solution or slurry.
It will be appreciated that the particle size of the materials making up the dry particulate mixture, and also the droplet size of the solution or slurry when sprayed thereon, will influence the particle sizes found in the resulting pre-mix. By varying these parameters, it is possible to produce pre-mixes having different particles size distribution and in which the active ingredient is present in a large number of very minute particles, or in a lesser number of relatively large particles. Thus the invention makes it possible for a pre-mix to be tailored to meet different product requirements. The general principles governing the effects of substrate particle size, solution/slurry viscosity, spraying nozzle design and spraying pressure are well known to those skilled in food technology and related arts, and the techniques required for the physical production of a pre-mix in accordance with the invention are in themselves quite standard technology.
- 10 4 6 0 9 3
As far as the particle size cf the ingredients in the dry particulate mixture is concerned, we have found that standard commercially-available ingredients are quite adequate.
Standard flours, in which, for example, all but a trace of the 5 particles are less than 20Cp in diameter, are perfectly suitable. So too are commercially-available whey powder and lactose powder. In general, it can be stated that each ingredient of the dry particulate mixture should preferably have a particle size such that at least 3C;3 by weight of the
1C ingredient will pass through a 50Cp screen, and ideally at least 90? by weight of each ingredient will pass through such a screen.
Preferably the quantity of solution ar slurry applied to the dry particulate mixture, and the spraying conditions used, should be selected such that the resulting pre-mix contains at least about 1000 lactose-bound particles containing the active ingredients per gram of prs-mix. Ideally a pre-mix of the invention will contain an even higher number of lactose-bound particles containing the active ingredients, and a level of at least about 2000 lactose-bound particles containing the active ingredient per gram of pre-mix should be aimed for. In an ideal pre-mix according to the invention, at least about 95* by weight of the active ingredient will be contained in distinct lactose-bound particles separable from the bulk of the pre-mix.
A pre-mix of the invention can be incorporated in a human or animal foodstuff by simple admixture, the proportion of
- 11 >16033 pre-mix per unit weight of the foodstuff being chosen with regard to the concentration of the active ingredient present in the pre-mix and the concentration of the active ingredient desired in the foodstuff. In the preparation of compounded animal feedstuffs, the pre-mix can be added to nutrient materials at the milling stage. The nature of the nutrient materials that comprise the human or animal foodstuff in which the pre-mix is incorporated is not critical to the invention. Any of the usual protein, carbohydrate and fat materials can be used.
The pre-mix of the invention is a vendable product in its own right, as it can be sold for incorporation in foodstuffs made by different manufacturers.
Specific embodiments of the invention will now be described, by way of example only.
. Exawlg_l
250 kg of a dry particulate mixture was prepared by mixing together the following ingredients:
Ingredient
Dried wheat flour 58
Cheese whey powder 38
Citric acid 4
The dried wheat flour was a commercial product containing
4.8? moisture by weight. Over 99? by weight of the flour passed through a 195p screen. The cheese whey powder was also a commercial product, containing 6.1? by weight of moisture. Over 99? by weight of the whey powder passed through 532p
- 12 4 0 0 9 3 screen, and over 68% by weight passed through a 195'J screen.
The dry particulate mixer was fed to a Gardner horizontal ribbon mixer fitted with 6 hollow-cone M2 spraying nozzles. While the dry particulate mixture was intensely agitated in the 5 mixer, it was sprayed with 12.5 litres (5? by weight) of an aqueous slurry of E, coli endotoxin material prepared according to procedure A of Example 3 of Patent specification No.
3532Ί and in which slurry hac been incorporated 125 gm of a commercially-available food-grade red azo dyestuff. Tne i; activity of the slurry was 3000 haemagglutination units of endotoxins for each E, coli serotype per ml. Spraying time was 30 minutes. Mixing was continued for several minutes after completion of spraying, to ensure even distribution of the pre-mix ingredients.
The pre-mix so formed was seen to comprise a free-flowing powder of very pale pink colour uniformly throughout which war. dispersed a large number of tiny, hard, intensely-coloured red particles.
The intensely-coloured particles could be readily serparated from the bulk of the pre-mix, and analysis revealed that over 98% of both the dyestuff and the vaccine activity resided in the intensely-coloured particles.
A particle size analysis of the pre-mix yielded the following result:
- 13 V.
f> bv weight of
Particle diameter (μ)
• pre-mix > 1999 0.4 800 - 1999 3.4 600 - 799 2.6 350 - 599 4.0 250 - 349 6.4 J 49 - 249 17.0 125 - 148 11.4 74 - 124 38.6 < 74 16.2
A particle count made on a sample of the pre-mix revealed that there were approximately 5000 intensely-coloured lactose-bound particles per gram of the pre-mix»
This pre-mix was incorporated at levels of 0.5, 1.0 and
1.52 by weight in a standard feed composition for young pigs. The feed composition was milled and pelletted to give a creep feed consisting of small pellets, one gram of feed consisting of approximately 10 pellets. On average, each pellet would have contained 2.5 lactose-bound particles at the 0.5? inclusion level. Pigs fed on these feeds accepted them readily, and enjoyed the prophylactic benefits described in our
Patent specification No. 35321.
Examples. 2._and 3
The procedure of Example 1 was repeated on two further
250kg batches of a dry particulate mixture of composition identical to that used in Example 1. In this instance,
- 14 4 6 0 9 3 however, both batches were sprayed with 7 litres (2.8? by weight) of the aqueous slurry, and in Example 3 the M2 spraying nozzles were replaced by M6 nozzles. The spraying time in Example 2 was 12 minutes, and in Example 3 it was 5.5 minutes.
As in Example 1, a pre-mix consisting of a large number of minute intensely-coloured particles distributed uniformly through a pale-coloured powder resulted. The M6 nozzle induced the formation of some larger particles, consistent with the larger droplet size associated with this nozzle. However, the pre-mix of Example 3 was in no way inferior to that of
Example 2. A particle size analysis of each pre-mix gave the following results:
IJaLMigtaLae
J2rs=ai2
Sxsmnls-Z. Sam
> 1993 0.2 0.4 800 - 1999 0.4 3.6 600 - 799 0.6 3.0 350 - 599 2.2 2.2 250 - 349 6.4 2.6 149 - 249 50.6 29.6 125 - 148 11.4 13.4 74 - 124 15.0 29.6 < 74 13.2 15.4
The pre-mixes of Example 2 and Example 3 were each incorporated in standard pig feed compositions, and gave excellent results in feeding trials.
- 15 4609 3
Claims (23)
1. A process for the preparation of a pre-mix, in which as’herein before defined ι process a dry particulate mixture of an edible inert powder/ and j ί / a lactose source, the lactose content of the mixture being from 5 20 to 50? by weight, is intensely agitated and while so intensely agitated is sprayed with an aqueous solution or slurry of an active ingredient (as hereinbefore defined), the solution or slurry being applied in an amount of from 1 to 12? by weight of the dry particulate mixture. 10
2. A process according to Claim 1 in which the lactose content of the dry particulate mixture is at least 22? by weight.
3. A process according to Claim 2 in which the lactose content of the dry particulate mixture is at least 25? by 15 weight.
4. A process according to any one of Claims 1 to 3 in which the lactose content of the dry particulate mixture is not greater than 45? by weight.
5. A process according to Claim 4 in which the lactose 2θ content of the dry particulate mixture is not greater than 35? by weight.
6. A process according to any one of the preceding Claims in which the amount of solution or slurry applied to the dry particulate mixture is at least 2? by weight. _IG.4 S Ο 9 3
7. A process according to any one of the preceding Claims in which the amount of solution or slurry applied to the dry particulate mixture is no greater than 10? by weight. 3. A process according to Claim 7 in which the amount of 5 solution or slurry applied to the dry particulate mixture is not greater than 6? by weight.
8. 9. A process according to any one of the preceding Claims in which the edible inert powder is a flour.
9. 10. A process according to Claim 9 in which the flour has 10 a moisture content of less than 10? by weight.
10. 11. A process according to any one of the preceding Claims in which the lactose source is whey powder.
11. 12. A process according to Claim 11 in which the dry particulate mixture comprises, by weight, from 40 to 70? of the 15 edible inert powder and from 60 to 30? of whey powder.
12. 13. A process according to Claim 12 in which the dry particular mixture comprises, by weight, from 50 to 65? of the edible inert powder and from 35 to 50? of whey powder.
13. 14. A process according to any one of the preceding 20 Claims in which the dry particulate mixture additionally comprises an edible organic cr an edible acid salt.
14. 15. A process according to Claim 14 in which the weak edible acid Is citric acid.
15. 16. A process according to Claim 14 or Claim 15 in which 25 the weak edible acid comprises from 1 to 10? by weight of the dry particulate mixture. - ιΊ 46093
16. 17. A process according to any one of the preceding Claims in which the solution or slurry incorporates a food-grade colouring agent.
17. 18. A process according to any one of the preceding Claims 5 in which the active ingredient is an oral vaccine comprising endotoxins derived from one or more bacterial strains implicated in gastro-intestinal disorders, the endotoxins being substantially free from association with any living bacteria.
18. 19. A pre-mix according to claim 18 in which the 10 endotoxins are derived from any one or more of the E.coli strains 08, 09, 015, 020, 045, 078, 0114, 0137, 0138, 0139, 0141, 0147 and 0149 and/or Salmonella dublin and/or Salmonella tvphimunium.
19. 20. A process for the preparation of a pre-mix, 15 substantially as hereinbefore described in any one of the Examples.
20. 21. A pre-mix which has been prepared by a process according to any one of the preceding Claims.
21. 22. The manufacture of a foodstuff for human or animal consumption which involves mixing with nutrient material a pre-mix according to Claim 21.
22.
23. A foodstuff for human or animal consumption which comprises nutrient material and a pre-mix according to Claim 21.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48808/76A GB1596505A (en) | 1976-11-23 | 1976-11-23 | Food manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
IE46093L IE46093L (en) | 1978-05-23 |
IE46093B1 true IE46093B1 (en) | 1983-02-23 |
Family
ID=10449977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2348/77A IE46093B1 (en) | 1976-11-23 | 1977-11-18 | Food manufacture |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS5379046A (en) |
AT (1) | AT368841B (en) |
AU (1) | AU514767B2 (en) |
BE (1) | BE861026A (en) |
CA (1) | CA1097979A (en) |
CS (1) | CS235066B2 (en) |
DE (1) | DE2751614C2 (en) |
DK (1) | DK147152C (en) |
ES (1) | ES464337A1 (en) |
FR (1) | FR2392675A1 (en) |
GB (1) | GB1596505A (en) |
GR (1) | GR66160B (en) |
IE (1) | IE46093B1 (en) |
IN (1) | IN147365B (en) |
IT (1) | IT1091299B (en) |
LU (1) | LU78570A1 (en) |
NL (1) | NL7712830A (en) |
NO (1) | NO147818C (en) |
SE (1) | SE433033B (en) |
YU (1) | YU43204B (en) |
ZA (1) | ZA776963B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3062867D1 (en) * | 1980-04-01 | 1983-06-01 | Sumitomo Chemical Co | Process for the production of water-soluble biotin-containing preparations and their use as additives to feed supplements |
FR2526273A1 (en) * | 1982-05-04 | 1983-11-10 | Guibert Jacques | Mixing heat sensitive food and medicinal substances - with material that melts above 40 deg. C and is solid below 30 Deg. C. |
HU191244B (en) * | 1984-01-06 | 1987-01-28 | Egyt Gyogyszervegyeszeti Gyar | Dust mixture of high propylene-glycol content and process for producing same |
HU191245B (en) * | 1984-01-06 | 1987-01-28 | Egis Gyogyszergyar,Hu | Process for the production of stbale pharmaceutical preparation against ketosis |
ES2076123B1 (en) * | 1993-10-25 | 1996-05-16 | Alimentacion Menorca S L Alime | AROMATIC BALLOONS FOR THE FORMULATION OF COMPOUND FEED IN ANIMAL FEEDING. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE640508A (en) * | ||||
DE375668C (en) * | 1921-11-08 | 1923-05-17 | Chem Fab Helfenberg A G | Process for the production of high-percentage, durable and air-resistant glycerine preparations in powder form |
DE728335C (en) * | 1938-02-09 | 1942-11-25 | Dr Erich Thomae | Process for the production of oil preparations in solid form |
US3055804A (en) * | 1961-03-29 | 1962-09-25 | American Cyanamid Co | Mange powders |
DE1517044A1 (en) * | 1962-06-04 | 1969-05-14 | Hoffmann La Roche | Process for the vitaminization of food and feed |
CH433944A (en) * | 1962-12-17 | 1967-04-15 | Hoffmann La Roche | Preparation for adding vitamins to food and animal feed and process for the production thereof |
DE1793190A1 (en) * | 1963-04-15 | 1971-12-16 | Du Pont | Process for the preparation of 1-amino-adamantanes |
BE658119A (en) * | 1964-11-23 | 1965-04-30 | ||
FR1488271A (en) * | 1966-03-21 | 1967-07-13 | Chimetron Sarl | New anthelmintics imidazothiazole |
US3617302A (en) * | 1968-07-08 | 1971-11-02 | Kraftco Corp | Preparation of a flowable particulate composition |
GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
US3919408A (en) * | 1973-03-26 | 1975-11-11 | Gen Foods Corp | Alcohol-containing oral hygiene powders |
GB1462384A (en) * | 1973-04-12 | 1977-01-26 | Unilever Ltd | Rearing of lambs |
FR2297630A1 (en) * | 1975-01-15 | 1976-08-13 | Pfizer | Control of pig dysentery using oleandomycin - in feed at level of at least 5.5 ppm |
-
1976
- 1976-11-23 GB GB48808/76A patent/GB1596505A/en not_active Expired
-
1977
- 1977-11-17 YU YU2739/77A patent/YU43204B/en unknown
- 1977-11-18 GR GR54842A patent/GR66160B/el unknown
- 1977-11-18 IN IN328/BOM/77A patent/IN147365B/en unknown
- 1977-11-18 IE IE2348/77A patent/IE46093B1/en not_active IP Right Cessation
- 1977-11-18 DE DE2751614A patent/DE2751614C2/en not_active Expired
- 1977-11-18 AU AU30757/77A patent/AU514767B2/en not_active Expired
- 1977-11-21 NO NO773979A patent/NO147818C/en unknown
- 1977-11-21 CA CA291,277A patent/CA1097979A/en not_active Expired
- 1977-11-21 ES ES464337A patent/ES464337A1/en not_active Expired
- 1977-11-21 FR FR7734890A patent/FR2392675A1/en active Granted
- 1977-11-21 AT AT0830777A patent/AT368841B/en not_active IP Right Cessation
- 1977-11-21 BE BE182790A patent/BE861026A/en not_active IP Right Cessation
- 1977-11-22 SE SE7713188A patent/SE433033B/en not_active IP Right Cessation
- 1977-11-22 ZA ZA00776963A patent/ZA776963B/en unknown
- 1977-11-22 NL NL7712830A patent/NL7712830A/en not_active Application Discontinuation
- 1977-11-22 IT IT69638/77A patent/IT1091299B/en active
- 1977-11-22 DK DK517877A patent/DK147152C/en not_active IP Right Cessation
- 1977-11-22 JP JP14058777A patent/JPS5379046A/en active Pending
- 1977-11-23 LU LU78570A patent/LU78570A1/xx unknown
- 1977-11-23 CS CS777746A patent/CS235066B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK147152B (en) | 1984-04-30 |
SE7713188L (en) | 1978-05-24 |
CS235066B2 (en) | 1985-04-16 |
YU273977A (en) | 1984-02-29 |
AU514767B2 (en) | 1981-02-26 |
AT368841B (en) | 1982-11-10 |
NO147818C (en) | 1983-06-22 |
LU78570A1 (en) | 1978-07-12 |
CA1097979A (en) | 1981-03-24 |
FR2392675A1 (en) | 1978-12-29 |
BE861026A (en) | 1978-05-22 |
DK147152C (en) | 1984-09-17 |
IN147365B (en) | 1980-02-09 |
IT1091299B (en) | 1985-07-06 |
IE46093L (en) | 1978-05-23 |
ZA776963B (en) | 1979-06-27 |
ES464337A1 (en) | 1978-12-01 |
NO147818B (en) | 1983-03-14 |
YU43204B (en) | 1989-06-30 |
GR66160B (en) | 1981-01-20 |
SE433033B (en) | 1984-05-07 |
FR2392675B1 (en) | 1980-02-29 |
NO773979L (en) | 1978-05-24 |
ATA830777A (en) | 1982-04-15 |
DE2751614A1 (en) | 1978-05-24 |
DK517877A (en) | 1978-05-24 |
GB1596505A (en) | 1981-08-26 |
JPS5379046A (en) | 1978-07-13 |
AU3075777A (en) | 1979-05-24 |
NL7712830A (en) | 1978-05-25 |
DE2751614C2 (en) | 1984-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1289807C (en) | Food product | |
EP0383116B1 (en) | Animal feed composition | |
SK42097A3 (en) | Animal feed of higher nutritive value, method for production thereof and use of a polyethylene glycol compound | |
JP2002515229A (en) | Use of thymol-containing natural substances in the production of animal feed | |
JPS59106256A (en) | Production of granular nutritions substance | |
CA1154294A (en) | Feed additive passing through the rumen of ruminants and its use for feeding ruminants | |
EP0755195B1 (en) | Method for producing animal feed of higher nutritive value, and the use of the animal feed thus produced | |
EP1916907B1 (en) | Animal feed | |
IE46093B1 (en) | Food manufacture | |
US4680315A (en) | Powder mixture having high propylene glycol content and process for the preparation thereof | |
CN112715759A (en) | Anti-caking small-particle pet nutritional supplement and preparation method thereof | |
JP6189567B1 (en) | Method for producing protein-containing granules | |
FI61789C (en) | REFERENCE TO A FRAME RELEASE | |
US2973266A (en) | Stabilization of fat-soluble vitamin | |
FI109760B (en) | A process for the preparation of a semduramycin-containing animal feed premix | |
JPH10146156A (en) | Pellet feed for pig | |
JP3611382B2 (en) | Lecithin-containing powder | |
JPH09191855A (en) | Calcium potentiating agent | |
WO1988006410A1 (en) | Animal feedstuff | |
JP2916959B2 (en) | Mineral feed | |
PL115472B1 (en) | Fodder appropriated for pigs not being afflicted with dysentery | |
JPH08319232A (en) | Particulate composition | |
JPH09131163A (en) | Lecithin-containing powder | |
JP2002176934A (en) | Granular food and method for producing the same | |
JP2022128903A (en) | Substitute milk and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |